Muhammad Akbar Ramadhan Munandar, Hendra Priatna Munandar and Liana Herlina (2026) “Cost-Effectiveness of Pembrolizumab as First-Line Treatment for PD-L1 Positive NSCLC: A Systematic Review”, The International Journal of Medical Science and Health Research, 23(2), pp. 64–130. doi:10.70070/h3zdy035.